Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Evaluation of ocular pharmacokinetics of ck41016, a novel drug candidate for the treatment of age-related macular degeneration

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHO, Hea-Young (CHA University, College of Pharmacy, Seongnam-si, Korea, Republic Of)
  • Co-author(s): Hwajin Shin: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
    Seong-Moon Cheon: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
    Sook-Jin Kim: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
    Yong-Bok Lee: College of Pharmacy, Chonnam National University, Gwangju, Korea, Republic Of
    Hea-Young Cho: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
  • Abstract:

    Background

    CK41016 as a new drug candidate is a breakthrough for age-related macular degeneration (AMD). AMD damages to the macula of the retina and causes adult blindness. Current therapy of AMD is an intravitreal injection and can cause endophthalmitis, retinal detachment and increased intraocular pressure. Therefore, topical and non-invasive

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses